TRENEICE LONDON: Open Payments
NPI 1114375300 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 56 payments from 13 companies in 2025. Trend: 2023 $1,500 · 2024 $2,583 · 2025 $1,337
Food & beverage: $1,337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $413 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $268 |
| PFIZER INC. | 11 | $168 |
| Novo Nordisk Inc | 7 | $116 |
| Phathom Pharmaceuticals, Inc. | 7 | $80 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Antares Pharma, Inc. | 3 | $64 |
| SPR Therapeutics, Inc | 1 | $48 |
| Forte Bio-Pharma LLC | 2 | $38 |
| Abbott Laboratories | 1 | $26 |
Products named: Kerendia, VRAYLAR, NURTEC ODT, QULIPTA, UBRELVY, VOQUEZNA, Ozempic, SHINGRIX.
Industry payments across NC — which companies pay providers there.
